AKT1 and pulmonary fibrosis: In addition, this work, for the first time, provides evidence that nintedanib improved oxidative stress, inhibited inflammatory response, and improved lung tissue apoptosis by downregulating PI3K/Akt/mTOR signaling pathway, ultimately improving lung fibrosis.